OTC Healthcare in Egypt
Euromonitor International's OTC Healthcare in Egypt market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 72 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Egypt’s high population and rising health awareness stimulates demand for OTC healthcare
Egypt is the largest producer and consumer of pharmaceutical products in the MENA region, with 364 registered companies producing a wide array of drugs and medical equipment. The Egyptian OTC healthcare market enjoyed an 8% value CAGR during the review period. One of the major driving forces for the growth of the OTC market in Egypt was the large population which exceeds 70 million, growing annually at a rate of around 2%. Moreover, increasing health awareness, borne of greater urbanisation and rise in income along with exposure to international media, increased demand for OTC drugs, such as vitamins and remedies for various common ailments. With a population that is expected to increase by 50% to 112 million by 2025 as life expectancy increases, Egypt represents a golden opportunity to long-term investors, especially in the OTC healthcare industry.
TRIPS Agreement effective in Egypt’s pharmaceutical industry as of January 2005
As of January 2005, Egypt had to be fully compliant with the stipulations of the Trade-related Intellectual Property Rights (TRIPS) Agreement with regards to its pharmaceutical industry. Although TRIPS came into force in 1995, developing countries were given an extension until 2000 to be able to prepare for the changes instigated by enforcement of the Agreement. A further five-year grace period was granted to these countries for pharmaceuticals. Egypt chose to utilise the full 5-year grace period to prepare for the TRIPS implementation on its pharmaceutical sector, which is one of the country’s most important industries.
Local producers face challenges complying with new IP laws
There was a lot of national opposition with regards to the implementation of the TRIPS Agreement on the pharmaceutical industry in Egypt. Local companies rushed to create new products due to the fear of impending competition from multinational and foreign companies. Egypt is the MENA region’s largest producer of generic drugs and the new IP law left local companies planning joint mergers to be able to compete with such international pharmaceutical leaders as Pfizer and GlaxoSmithKline Plc. The merger concept is one that the Egyptian Ministry of Health is not advocating. Although the new IP laws do not apply to drugs that are already in the Egyptian market, many voiced concerns that the laws will cause a significant rise in the prices of newly created, high-tech IP-protected drugs. If Egypt is unable to re-produce these drugs out of generics, they must be bought from foreign companies at expensive prices, unaffordable to the vast majority of the Egyptian population. This would be compounded by the inability of the Egyptian government to subsidise such medicines at a national level.
Vitamins and dietary supplements lead the OTC healthcare market
Rising health awareness in Egypt prompted consumers to purchase preventative OTC healthcare to improve their health. Vitamins and Dietary supplement sales therefore rose over the review period as upper and middle income consumers purchase them on a regular basis, in particular the premium and or/imported brands, thereby boosting value sales. In addition, poor nutrition and dietary habits in Egypt caused a widespread phenomenon of vitamin, protein and mineral deficiency amongst a large percentage of the lower-income sector, for whom vitamins and supplements are prescribed by their local physicians to support their health. They purchase the less expensive brands, but their consumption is a boost to volume sales as they constitute a significant portion of the population. Vitamins and dietary supplement sales reached £E470 in 2005, which is a considerable 24% value share of the total OTC healthcare market. The sector is anticipated to remain the leader within the forecast period.
Child-specific OTC healthcare still in its developing stages, but expected to grow
Child-specific OTC healthcare only registered sales of £E77 million in 2005, a mere 4% of the total OTC healthcare market. Egyptian parents are wary of administering medication to their children, and those who do, usually give them their own adult medications but in smaller doses. This is partly owing to lack of awareness concerning child-specific remedies, but also a factor of low purchasing power as many families are unable to afford both adult and child versions of medications. However, as income, literacy and health awareness are on the rise in Egypt, child-specific OTC healthcare is expected to grow, especially due to the fact that the Egyptian population increases at a rate of over 2% per annum, meaning that a large part of the country’s population is below the age of 15.
Table of contents
OTC HEALTHCARE IN EGYPT : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - EGYPT
EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO SAE (EIPICO) - OTC HEALTHCARE - EGYPT
COMPANY BACKGROUND
RECENT NEWS
PRODUCTION CAPACITY
GLOBAL NAPI PHARMACEUTICALS - OTC HEALTHCARE - EGYPT
COMPANY BACKGROUND
RECENT NEWS
SEDICO PHARMACEUTICAL CO - OTC HEALTHCARE - EGYPT
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Sedico Pharmaceutical Co: Products Launched during 2005
ANALGESICS IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Systemic adult analgesics are the top-selling OTC healthcare product
Standard analgesics more popular than herbal/traditional analgesics
Adult analgesics
Child-specific analgesics
Topical analgesics
Forecast performance
Analgesics will remain the third largest OTC healthcare sector
Topical analgesics the most dynamic
Child-specific analgesics expected to show gradual growth
Table 11 Sales of Analgesics by Subsector: Value 2000-2005
Table 12 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 13 Analgesics Company Shares by Retail Value 2001-2005
Table 14 Analgesics Brand Shares by Retail Value 2002-2005
Table 15 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 16 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Table 17 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Cough, cold and allergy remedies constitute the second-biggest OTC market
Combination products remain the most popular
Child-specific products the smallest
Decongestants the most dynamic
Anti-histamines/allergy remedies sales pushed forward by smoke from crop-burning
Forecast
Cough remedies register higher sales than combination products
Oral decongestants the most dynamic
Child-specific cough, cold and allergy remedies show promising growth
Medicated confectionery continues to acquire popularity with its diverse distribution and multi-purpose consumption
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Table 25 Sales of Decongestants by Type: Value 2000-2005
Table 26 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 28 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Digestive remedies the most dynamic amongst OTC healthcare
Indigestion and heartburn remedies top sales owing to unhealthy dietary habits
Laxatives perform well as young girls incorrectly use them for weight loss purposes
Child-specific digestive remedies constitute small subsector
Forecast performance
Digestive remedies to continue to show steady growth
Diarrhoeal remedies will be the most dynamic owing to bad dietary habits
IBS treatments remain negligible
Table 29 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 31 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 32 Digestive Remedies Brand Shares by Retail Value 2002-2005
Table 33 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 34 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Table 35 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
Table 36 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 37 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN EGYPT
SECTOR PERFORMANCE
2005 headlines
2005 a good year for medicated skin care
Topical antifungals leads sales
Hair loss treatments the most dynamic
Child-specific medicated skin care negligible
Forecast performance
Topical antifungals to remain in lead
Antipruritics second in line
Hair loss treatments to remain most dynamic
Lip care treatments small as Egyptian Women prefer cosmetic products
Table 38 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 40 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 41 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Table 44 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Table 45 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Table 46 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Vitamins and dietary supplements remain the number one OTC healthcare sector
Dietary supplements leads the way
Mineral supplements consumed the most owing to high rate of IDA
Child-specific products not popular
Tonics and bottled nutritive drinks negligible
Forecast performance
Dietary supplements continues to lead the sector
Amongst Vitamins, vitamin D will become the most dynamic to prevent rickets and diabetes
Amongst dietary supplements, fish oils will become the most dynamic also to prevent rickets, diabetes and VAD
Tonics and bottled nutritive drinks remain unpopular
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 49 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 50 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
Multivitamins remains the most popular
Amongst single vitamins, vitamin B registered the highest sales
Vitamin D and vitamin C the most dynamic
Table 53 Sales of Vitamins by Type: Value 2000-2005
Table 54 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 55 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Mineral supplements takes the lead
Calcium supplements rank second
Royal jelly and gingko biloba gain popularity for perceived role as sexual enhancers
Table 56 Sales of Dietary Supplements by Type: Value 2000-2005
Table 57 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 58 Dietary Supplements Brand Shares by Retail Value 2002-2005
NRT SMOKING CESSATION AIDS IN EGYPT
NUMBER OF SMOKERS
Table 59
SECTOR PERFORMANCE
2005 headlines
Forecast performance
EYE CARE IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Eye care sector performing well
Standard eye care dominates
Allergy eye care still small, but more dynamic than standard eye care
Forecast performance
Table 60 Sales of Eye Care by Subsector: Value 2000-2005
Table 61 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 62 Eye Care Company Shares by Retail Value 2001-2005
Table 63 Eye Care Brand Shares by Retail Value 2002-2005
Table 64 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 65 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN EGYPT
SECTOR PERFORMANCE
Ear care the smallest amongst the OTC healthcare market
Ear care expected to show the most dynamic growth amongst OTC healthcare during forecast period
ADULT MOUTHCARE IN EGYPT
SECTOR PERFORMANCE
Adult mouthcare still a rudimentary market
Minor growth expected during forecast period
CALMING AND SLEEPING PRODUCTS IN EGYPT
SECTOR PERFORMANCE
Calming and sleeping products modest growth
WOUND TREATMENTS IN EGYPT
SECTOR PERFORMANCE
2005 headlines
Wound treatments going strong
Sticking plasters account for all sales of wound treatments
Forecast performance
Table 66 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 67 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 68 Wound Treatments Company Shares by Retail Value 2001-2005
Table 69 Wound Treatments Brand Shares by Retail Value 2002-2005
Table 70 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 71 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN EGYPT
SECTOR PERFORMANCE
Emergency contraception negligible owing to cultural and religious hindrances